MyFinsight
Home
Blog
About
Contact
Download
Download image
Assets of disposal
group held-for-sale
$83,170,009
Cash and cash
equivalents
$2,517,218
Other current assets
$1,521,939
Prepaid expenses
$451,879
Accounts receivable
$37,490
Goodwill
$25,796,163
Intangible assets,
net-Developed Technology...
$18,387,000
Intangible assets,
net-Customer Relationships
$2,630,000
Intangible assets,
net-Trade Names
$782,000
Deposits
$49,122
Property and equipment,
net
$27,520
Total current assets
$87,698,535
Total other assets
$47,671,805
Total assets
$135,370,340
Total liabilities,
mezzanine equity and...
$135,370,340
Total mezzanine
equity-Series GPreferred...
$61,681,100
Total liabilities
$45,808,262
Total stockholders'
equity (deficit)
$27,880,978
Accumulated deficit
-$205,798,707
Total current
liabilities
$33,516,161
Due to related party
$7,292,101
Deferred consideration-
long term
$5,000,000
Additional paid-in capital
$228,392,426
Non-controlling interest
$5,287,000
Common stock - par value
0.0001 per share...
$255
Preferred stock-Series
HPreferred Stock
$4
Liabilities held-for-sale
$23,672,708
Accounts payable
$4,973,285
Deferred consideration-
short term
$2,000,000
Accrued dividend
payable
$1,564,753
Line of credit
$700,000
Accrued expenses
$410,324
Operating lease
liabilities - current
$135,609
Other current
liabilities
$59,482
Back
Back
Balance Sheet
source: myfinsight.com
Entero Therapeutics, Inc. (ENTO)
Entero Therapeutics, Inc. (ENTO)